跳至主要内容
临床试验/NCT03557567
NCT03557567已完成不适用

NGS Strategy Effectiveness in Molecular Diagnosis

Istituto Ortopedico Rizzoli0 个研究点目标入组 400 人开始时间: 2014年9月29日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
400
主要终点
Assessment of the accuracy of the Ion Torrent PGM platform for genetic variant detection (Diagnostic sensitivity evaluation)

研究概览

简要总结

The coming out of Next Generation Sequencing (NGS) technologies, with documented advantages and reduced costs respect to Sanger sequencing, has provided new appealing approaches to diagnostic testing. Despite this, its use for routine diagnostic purposes requires certification in terms of reliability, as well as a cost-effectiveness evaluation.

To test the feasibility of using the Ion Torrent Personal Genome Machine (PGM) in clinical diagnosis, we assessed its performance to detect point mutations and big rearrangements previously identified with standard techniques. The diagnostic accuracy and the cost-effectiveness will be evaluated by Health Technology Assessment (HTA) analyses.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of Multiple Osteochondroma
  • Clinical diagnosis of Osteogenesis Imperfecta

排除标准

  • 未提供

结局指标

主要结局

Assessment of the accuracy of the Ion Torrent PGM platform for genetic variant detection (Diagnostic sensitivity evaluation)

时间窗: at 30 months

The accuracy of the Ion Torrent Personal Genome (PGM) to identify disease-causing mutations in patients affected by Multiple Osteochondromas (MO) and Osteogenesis Imperfecta (OI) needs to be validated for its routine diagnostic clinical use. To asses this, we will compare results obtained with the new NGS approach with those previously obtained with standard techniques (DHPLC/Sanger + MLPA) in a number of MO and OI patients.

HTA analysis to assess the cost-effectiveness, organizational and social implications of a screening strategy based on the IonPGM platform

时间窗: at 36 months

To demonstrate the pertinence in the use of this innovative technology in health care, we will examine the medical, social and economic implications according with Health Technology Assessment (HTA), a multi-disciplinary field of policy analysis applied to many different health care technologies before their diffusion and use. HTA aims at evaluating the real effectiveness of medical interventions, their proper use, access criteria and qualitative improvements, the clinical and organizational benefits, therefore suggesting how to manage, promote and discourage them.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验

NGS Strategy Effectiveness in Molecular Diagnosis | 临床试验